In depth comparison of an individual’s DNA and its lymphoblastoid cell line using whole genome sequencing
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background: A detailed analysis of whole genomes can be now achieved with next generation sequencing. Epstein Barr Virus (EBV) transformation is a widely used strategy in clinical research to obtain an unlimited source of a subject’s DNA. Although the mechanism of transformation and immortalization by EBV is relatively well known at the transcriptional and proteomic level, the genetic consequences of EBV transformation are less well understood. A detailed analysis of the genetic alterations introduced by EBV transformation is highly relevant, as it will inform on the usefulness and limitations of this approach. Results: We used whole genome sequencing to assess the genomic signature of a low-passage lymphoblastoid cell line (LCL). Specifically, we sequenced the full genome (40X) of an individual using DNA purified from fresh whole blood as well as DNA from his LCL. A total of 217.33 Gb of sequence were generated from the cell line and 238.95 Gb from the normal genomic DNA. We determined with high confidence that 99.2% of the genomes were identical, with no reproducible changes in structural variation (chromosomal rearrangements and copy number variations) or insertion/deletion polymorphisms (indels). Conclusions: Our results suggest that, at this level of resolution, the LCL is genetically indistinguishable from its genomic counterpart and therefore their use in clinical research is not likely to introduce a significant bias.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Morin, R. D., Mendez-Lago, M., Mungall, A. J., Goya, R., Mungall, K. L., Corbett, R. D., Johnson, N. A., Severson, T. M., Chiu, R., Field, M., et al. (2011) · Nature · doi:10.1038/nature10351 · Cited by 1,614 · cited 1×
“next generation) sequencing has become increasingly affordable [18], enabling the discovery of causative DNA variants in rare genetic diseases [19-21] and providing new insights into carcinogenesis and autoimmunity [22-32].”
BackgroundHuman Genome Sequencing Using Unchained Base Reads on Self-Assembling DNA Nanoarrays
Drmanac, R., Sparks, A. B., Callow, M. J., Halpern, A. L., Burns, N. L., Kermani, B. G., Carnevali, P., Nazarenko, I., Nilsen, G. B., Yeung, G., et al. (2010) · Science · doi:10.1126/science.1181498 · Cited by 1,212 · cited 2×
“(Mountain View, CA) (CGI, details on the technique in [34]).”
BackgroundAnalysis of Genetic Inheritance in a Family Quartet by Whole-Genome Sequencing
Roach, J. C., Glusman, G., Smit, A. F. A., Huff, C. D., Hubley, R., Shannon, P. T., Rowen, L., Pant, K. P., Goodman, N., Bamshad, M., et al. (2010) · Science · doi:10.1126/science.1186802 · Cited by 1,084
Whole-Genome Sequencing in a Patient with Charcot–Marie–Tooth Neuropathy
Lupski, J. R., Reid, J. G., Gonzaga-Jauregui, C., Rio Deiros, D., Chen, D. C. Y., Nazareth, L., Bainbridge, M., Dinh, H., Jing, C., Wheeler, D. A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908094 · Cited by 759 · cited 2×
“next generation) sequencing has become increasingly affordable [18], enabling the discovery of causative DNA variants in rare genetic diseases [19-21] and providing new insights into carcinogenesis and autoimmunity [22-32].”
BackgroundGenome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis
Baranzini, S. E., Mudge, J., van Velkinburgh, J. C., Khankhanian, P., Khrebtukova, I., Miller, N. A., Zhang, L., Farmer, A. D., Bell, C. J., Kim, R. W., et al. (2010) · Nature · doi:10.1038/nature08990 · Cited by 476 · cited 1×
“next generation) sequencing has become increasingly affordable [18], enabling the discovery of causative DNA variants in rare genetic diseases [19-21] and providing new insights into carcinogenesis and autoimmunity [22-32].”
BackgroundSelf-citationThe effects of EBV transformation on gene expression levels and methylation profiles
Çalışkan, M., Cusanovich, D. A., Ober, C., & Gilad, Y. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr041 · Cited by 134
Cited by
Toward better understanding of artifacts in variant calling from high-coverage samples
Li, H. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu356 · Cited by 892
A synthetic-diploid benchmark for accurate variant-calling evaluation
Li, H., Bloom, J. M., Farjoun, Y., Fleharty, M., Gauthier, L., Neale, B., & MacArthur, D. (2018) · Nature Methods · doi:10.1038/s41592-018-0054-7 · Cited by 253
Rose, S., Frye, R. E., Slattery, J., Wynne, R., Tippett, M., Pavliv, O., Melnyk, S., & James, S. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085436 · Cited by 168
“Genomic stability is very high at this low passage number [38,39].”
BackgroundGibbons, J. G., Branco, A. T., Yu, S., & Lemos, B. (2014) · Nature Communications · doi:10.1038/ncomms5850 · Cited by 165
In Vitro Human Cell Line Models to Predict Clinical Response to Anticancer Drugs
Niu, N., & Wang, L. (2015) · Pharmacogenomics · doi:10.2217/pgs.14.170 · Cited by 162
Metadata
- Authors
- Nickles, D., Madireddy, L., Yang, S., Khankhanian, P., Lincoln, S., Hauser, S. L., Oksenberg, J. R., & Baranzini, S. E.
- Venue
- BMC Genomics
- Published
- 2012-09-14
- Volume
- 13
- Issue
- 1
- Pages
- 477-477
- ISSN
- 1471-2164 (ISSN-L)
- OpenAlex
- W2028154001
- Cited by
- 37
- References
- 6
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In depth comparison of an individual’s DNA and its lymphoblastoid cell line using whole genome sequencing. https://app.cochat.ai/papers/10.1186/1471-2164-13-477
- The paper
- Nickles, D., Madireddy, L., Yang, S., Khankhanian, P., Lincoln, S., Hauser, S. L., Oksenberg, J. R., & Baranzini, S. E. (2012). In depth comparison of an individual’s DNA and its lymphoblastoid cell line using whole genome sequencing. BMC Genomics. https://doi.org/10.1186/1471-2164-13-477
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.